Osteoporosis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 50 years of age or older (there is no upper age limit)
- You had a bone fracture in the last 12 months that happened from a minor injury (such as a simple fall) affecting the hip, thigh bone, pelvis, spine, upper arm, or wrist
- You have a regular family doctor or primary care provider that you see
- You are able to provide a home mailing address
- You are able to stay in the same general area as the study location for the next several months, and travel there if needed
Who may not be able to join:
- You have taken any of the following bone or osteoporosis medications in the past 12 months: risedronate (Actonel/Atelvia), alendronate (Fosamax/Binosto), zoledronic acid (Reclast/Zometa/Aclasta), ibandronate (Boniva/Bondronat), pamidronate (Aredia), denosumab (Prolia), romosozumab (Evenity), abaloparatide (Tymlos), teriparatide (Forteo), parathyroid hormone (Natpara), raloxifene (Evista), bazedoxifene-conjugated estrogen (Duavee), or calcitonin (Miacalcin)
- You have been diagnosed with advanced kidney disease (stage 4 or 5) or are on dialysis
- You have been diagnosed with multiple myeloma (a type of blood cancer)
- You have been diagnosed with Addison's disease or adrenal insufficiency (conditions affecting hormone-producing glands)
- You are currently receiving hospice care
- You have had, or are expecting to have, a solid organ transplant (such as a kidney, liver, or heart transplant)
- You have had a bone marrow transplant
- You have a bone disease other than osteoporosis, such as Paget's disease, osteomalacia, osteogenesis imperfecta, or Cushing's disease
- Your fracture was caused by a serious accident, such as a car crash or a fall from a height of 2 feet or more
- Your fracture was caused by cancer or an infection in the bone
- You already have an appointment scheduled with a bone health specialist
- You are not able to give your own consent to participate due to cognitive impairment or dementia
- You are currently taking part in another research study that involves taking medication
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Kenneth Saag, MD, MSc, University of Alabama at Birmingham
Phone: 205-996-5025
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence of subsequent fracture
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.